Skip to content
Disclosery

EXANE DERIVATIVES: OC position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on OC, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 7,326 OC shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 7,326 shares
    Change vs previous 13F -14,849 shares

    0.31% of the 13F portfolio, value $544,284.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 22,175 shares
    Change vs previous 13F +6,170 shares

    0.57% of the 13F portfolio, value $2,028,887.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 16,005 shares
    Change vs previous 13F +11,022 shares

    0.35% of the 13F portfolio, value $1,448,400.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,983 shares
    Change vs previous 13F +199 shares

    0.11% of the 13F portfolio, value $426,031.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 4,784 shares
    Change vs previous 13F +3,827 shares

    0.11% of the 13F portfolio, value $448,011.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 957 shares
    Change vs previous 13F +931 shares

    0.03% of the 13F portfolio, value $88,126.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 26 shares
    Change vs previous 13F 0 shares

    <0.01% of the 13F portfolio, value $1,970.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 26 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $1,789.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).